Close Menu

NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences on Thursday announced the acquisition of the flow cytometry business assets of ReaMetrix India for an undisclosed amount.

Beckman Coulter LS said that the deal provides it with "temperature-stable, single-dose, multicolor antibody cocktails targeting the HIV monitoring and clinical research markets." It added that ReaMetrix's products complement its flow cytometry product portfolio with reagents that streamline the sample preparation process and provide standardized reagent combinations to cytometry labs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.